Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment. 2021

Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
Institute of Anatomy, Rostock University Medical Center, Rostock, Germany.

The loss of myelinating oligodendrocytes is a key characteristic of many neurological diseases, including Multiple Sclerosis (MS). In progressive MS, where effective treatment options are limited, peripheral immune cells can be found at the site of demyelination and are suggested to play a functional role during disease progression. In this study, we hypothesize that metabolic oligodendrocyte injury, caused by feeding the copper chelator cuprizone, is a potent trigger for peripheral immune cell recruitment into the central nervous system (CNS). We used immunohistochemistry and flow cytometry to evaluate the composition, density, and activation status of infiltrating T lymphocytes in cuprizone-intoxicated mice and post-mortem progressive MS tissues. Our results demonstrate a predominance of CD8+ T cells along with high proliferation rates and cytotoxic granule expression, indicating an antigenic and pro-inflammatory milieu in the CNS of cuprizone-intoxicated mice. Numbers of recruited T cells and the composition of lymphocytic infiltrates in cuprizone-intoxicated mice were found to be comparable to those found in progressive MS lesions. Finally, amelioration of the cuprizone-induced pathology by treating mice with laquinimod significantly reduces the number of recruited T cells. Overall, this study provides strong evidence that toxic demyelination is a sufficient trigger for T cells to infiltrate the demyelinated CNS. Further investigation of the mode of action and functional consequence of T cell recruitment might offer promising new therapeutic approaches for progressive MS.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009836 Oligodendroglia A class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system. Interfascicular Oligodendroglia,Oligodendrocytes,Perineuronal Oligodendroglia,Perineuronal Satellite Oligodendroglia Cells,Perivascular Oligodendroglia,Satellite Cells, Perineuronal, Oligodendroglia,Perineuronal Satellite Oligodendrocytes,Interfascicular Oligodendroglias,Oligodendrocyte,Oligodendrocyte, Perineuronal Satellite,Oligodendrocytes, Perineuronal Satellite,Oligodendroglia, Interfascicular,Oligodendroglia, Perineuronal,Oligodendroglia, Perivascular,Perineuronal Satellite Oligodendrocyte,Satellite Oligodendrocyte, Perineuronal,Satellite Oligodendrocytes, Perineuronal
D003471 Cuprizone Copper chelator that inhibits monoamine oxidase and causes liver and brain damage. Biscyclohexanone Oxaldihydrazone,Oxaldihydrazone, Biscyclohexanone
D003711 Demyelinating Diseases Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. Clinically Isolated CNS Demyelinating Syndrome,Clinically Isolated Syndrome, CNS Demyelinating,Demyelinating Disorders,Demyelination,Demyelinating Disease,Demyelinating Disorder,Demyelinations
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
January 2013, Brain : a journal of neurology,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
January 2012, Experimental neurology,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
July 2013, Neurochemistry international,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
January 2017, Cell & bioscience,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
September 2002, Journal of neuroimmunology,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
December 2010, PloS one,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
October 2000, Molecular and cellular neurosciences,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
August 2005, Blood,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
January 2022, Neural regeneration research,
Hannes Kaddatz, and Sarah Joost, and Julia Nedelcu, and Uta Chrzanowski, and Christoph Schmitz, and Stefan Gingele, and Viktoria Gudi, and Martin Stangel, and Jiangshan Zhan, and Emily Santrau, and Theresa Greiner, and Julia Frenz, and Brigitte Müller-Hilke, and Michael Müller, and Sandra Amor, and Paul van der Valk, and Markus Kipp
January 2018, Frontiers in aging neuroscience,
Copied contents to your clipboard!